The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 6, Pages 1158
Publisher
MDPI AG
Online
2021-06-17
DOI
10.3390/v13061158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
- (2021) Gregory K. Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses
- (2020) Quazim A. Alayo et al. Scientific Reports
- Design and Rationale for First-In-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors
- (2020) Joshua D. Bernstock et al. HUMAN GENE THERAPY
- Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
- (2020) E. Antonio Chiocca et al. Molecular Therapy-Methods & Clinical Development
- Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice
- (2019) Joshua D. Bernstock et al. CANCER GENE THERAPY
- The Immunobiology of the Interleukin-12 Family: Room for Discovery
- (2019) Elia D. Tait Wojno et al. IMMUNITY
- Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance
- (2019) Stacie K. Totsch et al. ONCOGENE
- Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications
- (2019) Joshua D. Bernstock et al. JOURNAL OF NEUROSURGERY
- ATIM-14. RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47Δ IN PATIENTS WITH GLIOBLASTOMA
- (2019) Tomoki Todo NEURO-ONCOLOGY
- Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
- (2018) Gregory K. Friedman et al. Scientific Reports
- Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
- (2017) Myra E. van Linde et al. JOURNAL OF NEURO-ONCOLOGY
- Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors
- (2017) Alicia M. Waters et al. Human Gene Therapy Clinical Development
- The Herpes Simplex Virus Neurovirulence Factor γ34.5: Revealing Virus–Host Interactions
- (2016) Douglas R. Wilcox et al. PLoS Pathogens
- Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
- (2016) Daxa M. Patel et al. Human Gene Therapy Clinical Development
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Cancer-treatment-induced neurotoxicity—focus on newer treatments
- (2015) Jacqueline B. Stone et al. Nature Reviews Clinical Oncology
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011
- (2014) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Evaluation of the Safety and Biodistribution of M032, an Attenuated Herpes Simplex Virus Type 1 Expressing hIL-12, After Intracerebral Administration to Aotus Nonhuman Primates
- (2014) Justin C. Roth et al. Human Gene Therapy Clinical Development
- Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
- (2013) T. A. Cheema et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas
- (2012) Hideo Arai et al. Brain Tumor Pathology
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Transcriptional Profiles of CD133+ and CD133- Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
- (2010) C. Lottaz et al. CANCER RESEARCH
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
- Pharmacologic and Chemical Adjuvants in Tumor Virotherapy
- (2009) Christopher Alvarez-Breckenridge et al. CHEMICAL REVIEWS
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now